Federation Des Caisses Desjardins Du Quebec Bicycle Therapeutics PLC Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 61 shares of BCYC stock, worth $786. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 61
-0.0%
Holding current value
$786
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
112Shares Held
41.1MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$121 Million2.28% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.55MShares$45.7 Million2.97% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$30.2 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$29 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$25.2 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $383M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...